Acalabrutinib, ACP-196 CAS 1420477-60-6

Acalabrutinib, ACP-196 CAS 1420477-60-6

CAS NO: 1420477-60-6
Molecular Formula: C26H23N7O2
Molecular Weight: 465.51
EINECS NO: 814-272-0
MDL NO: MFCD29472294
Chat Now

Product Details

Product Description:

Product Name: Acalabrutinib, ACP-196 CAS NO: 1420477-60-6


Benzamide, 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-;



Chemical & Physical Properties:

Appearance : White to Off-white powder

Assay : ≥99.0%

Density: 1.4g/cm3

Melting point: >133℃

Boiling Point: N/A

Flash Point: N/A

Refractive Index: 1.715

Vapor Pressure: 0mmHg at 25°C

PSA: 118.51000

LogP: 3.904700

Solubility: Soluble in DMSO, not in water, Ethanol (Slightly), Methanol (Slightly).

DMSO : ≥125 mg/mL (268.52 mM);

H2O : < 0.1 mg/mL (insoluble)

Category: Standards; Pharmaceutical/API Drug Impurities/Metabolites;

Safety Information:

HS Code: 2934999090

Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.


Acalabrutinib (ACP196) is an experimental anti-cancer drug and a selective Bruton's tyrosine kinase (BTK) inhibitor.

Our factory manufacture’s Acalabrutinib CAS 1420477-60-6 , mature technology, stable output, quality assurance.

Inventory Status : In Stock.

We can provide 4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide COA (certificate of analysis),  ACP-196 CAS 1420477-60-6 MOA (Method of Analysis),CAS 1420477-60-6 ROS (Route of synthesis), Acalabrutinib MSDS (Material Safety Data Sheet) and other support for you !

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.


You Might Also Like